Industry: Chemical & Material
Published Date: 2025-02-21
Pages: 66 Pages
Report ld: 4161711
Request Sample
Customized Report
Pharmaceutical Grade L-Alanine Market Size(US$)

CAGR 2025-2031
3.8%
Market Size,2031
USD 8.8
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pharmaceutical Grade L-Alanine market size was US$ 6.8 million in 2024 and is forecast to a readjusted size of US$ 8.8 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
L-Alanine is a nonessential α-amino acid and which is a white crystalline solid or powder without odour. It can be dissolved in water, ethanol, insoluble in ether and acetone. In this report, we are study the Pharmaceutical Grade L-Alanine. Ajinomoto, Evonik and Kyowa Hakko is the major manufacturer of Pharmaceutical Grade L-Alanine in the world.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Pharmaceutical Grade L-Alanine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutical Grade L-Alanine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales and revenue of Pharmaceutical Grade L-Alanine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Pharmaceutical Grade L-Alanine manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Grade L-Alanine revenue, gross margin, and recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Sales channels analysis
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Pharmaceutical Grade L-Alanine Product Scope
1.2 Pharmaceutical Grade L-Alanine by Type
1.2.1 Global Pharmaceutical Grade L-Alanine Sales by Type (2020 & 2024 & 2031)
1.2.2 Purity: ≥99.5%
1.2.3 Others
1.3 Pharmaceutical Grade L-Alanine by Application
1.3.1 Global Pharmaceutical Grade L-Alanine Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Pharmaceuticals
1.3.3 Nutritional Supplements
1.4 Global Pharmaceutical Grade L-Alanine Market Estimates and Forecasts (2020-2031)
1.4.1 Global Pharmaceutical Grade L-Alanine Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Pharmaceutical Grade L-Alanine Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Pharmaceutical Grade L-Alanine Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Pharmaceutical Grade L-Alanine Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Pharmaceutical Grade L-Alanine Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Pharmaceutical Grade L-Alanine Sales Market Share by Region (2020-2025)
2.2.2 Global Pharmaceutical Grade L-Alanine Revenue Market Share by Region (2020-2025)
2.3 Global Pharmaceutical Grade L-Alanine Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Pharmaceutical Grade L-Alanine Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Pharmaceutical Grade L-Alanine Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Pharmaceutical Grade L-Alanine Market Size and Prospective (2020-2031)
2.4.2 Europe Pharmaceutical Grade L-Alanine Market Size and Prospective (2020-2031)
2.4.3 China Pharmaceutical Grade L-Alanine Market Size and Prospective (2020-2031)
2.4.4 Japan Pharmaceutical Grade L-Alanine Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Pharmaceutical Grade L-Alanine Historic Market Review by Type (2020-2025)
3.1.1 Global Pharmaceutical Grade L-Alanine Sales by Type (2020-2025)
3.1.2 Global Pharmaceutical Grade L-Alanine Revenue by Type (2020-2025)
3.1.3 Global Pharmaceutical Grade L-Alanine Price by Type (2020-2025)
3.2 Global Pharmaceutical Grade L-Alanine Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Pharmaceutical Grade L-Alanine Sales Forecast by Type (2026-2031)
3.2.2 Global Pharmaceutical Grade L-Alanine Revenue Forecast by Type (2026-2031)
3.2.3 Global Pharmaceutical Grade L-Alanine Price Forecast by Type (2026-2031)
3.3 Different Types Pharmaceutical Grade L-Alanine Representative Players
4 Global Market Size by Application
4.1 Global Pharmaceutical Grade L-Alanine Historic Market Review by Application (2020-2025)
4.1.1 Global Pharmaceutical Grade L-Alanine Sales by Application (2020-2025)
4.1.2 Global Pharmaceutical Grade L-Alanine Revenue by Application (2020-2025)
4.1.3 Global Pharmaceutical Grade L-Alanine Price by Application (2020-2025)
4.2 Global Pharmaceutical Grade L-Alanine Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Pharmaceutical Grade L-Alanine Sales Forecast by Application (2026-2031)
4.2.2 Global Pharmaceutical Grade L-Alanine Revenue Forecast by Application (2026-2031)
4.2.3 Global Pharmaceutical Grade L-Alanine Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Pharmaceutical Grade L-Alanine Application
5 Competition Landscape by Players
5.1 Global Pharmaceutical Grade L-Alanine Sales by Players (2020-2025)
5.2 Global Top Pharmaceutical Grade L-Alanine Players by Revenue (2020-2025)
5.3 Global Pharmaceutical Grade L-Alanine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Grade L-Alanine as of 2024)
5.4 Global Pharmaceutical Grade L-Alanine Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Pharmaceutical Grade L-Alanine, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Pharmaceutical Grade L-Alanine, Product Type & Application
5.7 Global Key Manufacturers of Pharmaceutical Grade L-Alanine, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Pharmaceutical Grade L-Alanine Sales by Company
6.1.1.1 North America Pharmaceutical Grade L-Alanine Sales by Company (2020-2025)
6.1.1.2 North America Pharmaceutical Grade L-Alanine Revenue by Company (2020-2025)
6.1.2 North America Pharmaceutical Grade L-Alanine Sales Breakdown by Type (2020-2025)
6.1.3 North America Pharmaceutical Grade L-Alanine Sales Breakdown by Application (2020-2025)
6.1.4 North America Pharmaceutical Grade L-Alanine Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Pharmaceutical Grade L-Alanine Sales by Company
6.2.1.1 Europe Pharmaceutical Grade L-Alanine Sales by Company (2020-2025)
6.2.1.2 Europe Pharmaceutical Grade L-Alanine Revenue by Company (2020-2025)
6.2.2 Europe Pharmaceutical Grade L-Alanine Sales Breakdown by Type (2020-2025)
6.2.3 Europe Pharmaceutical Grade L-Alanine Sales Breakdown by Application (2020-2025)
6.2.4 Europe Pharmaceutical Grade L-Alanine Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Pharmaceutical Grade L-Alanine Sales by Company
6.3.1.1 China Pharmaceutical Grade L-Alanine Sales by Company (2020-2025)
6.3.1.2 China Pharmaceutical Grade L-Alanine Revenue by Company (2020-2025)
6.3.2 China Pharmaceutical Grade L-Alanine Sales Breakdown by Type (2020-2025)
6.3.3 China Pharmaceutical Grade L-Alanine Sales Breakdown by Application (2020-2025)
6.3.4 China Pharmaceutical Grade L-Alanine Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Pharmaceutical Grade L-Alanine Sales by Company
6.4.1.1 Japan Pharmaceutical Grade L-Alanine Sales by Company (2020-2025)
6.4.1.2 Japan Pharmaceutical Grade L-Alanine Revenue by Company (2020-2025)
6.4.2 Japan Pharmaceutical Grade L-Alanine Sales Breakdown by Type (2020-2025)
6.4.3 Japan Pharmaceutical Grade L-Alanine Sales Breakdown by Application (2020-2025)
6.4.4 Japan Pharmaceutical Grade L-Alanine Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Ajinomoto
7.1.1 Ajinomoto Company Information
7.1.2 Ajinomoto Business Overview
7.1.3 Ajinomoto Pharmaceutical Grade L-Alanine Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Ajinomoto Pharmaceutical Grade L-Alanine Products Offered
7.1.5 Ajinomoto Recent Development
7.2 Evonik
7.2.1 Evonik Company Information
7.2.2 Evonik Business Overview
7.2.3 Evonik Pharmaceutical Grade L-Alanine Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Evonik Pharmaceutical Grade L-Alanine Products Offered
7.2.5 Evonik Recent Development
7.3 Kyowa Hakko
7.3.1 Kyowa Hakko Company Information
7.3.2 Kyowa Hakko Business Overview
7.3.3 Kyowa Hakko Pharmaceutical Grade L-Alanine Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Kyowa Hakko Pharmaceutical Grade L-Alanine Products Offered
7.3.5 Kyowa Hakko Recent Development
8 Pharmaceutical Grade L-Alanine Manufacturing Cost Analysis
8.1 Pharmaceutical Grade L-Alanine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Pharmaceutical Grade L-Alanine
8.4 Pharmaceutical Grade L-Alanine Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Pharmaceutical Grade L-Alanine Distributors List
9.3 Pharmaceutical Grade L-Alanine Customers
10 Pharmaceutical Grade L-Alanine Market Dynamics
10.1 Pharmaceutical Grade L-Alanine Industry Trends
10.2 Pharmaceutical Grade L-Alanine Market Drivers
10.3 Pharmaceutical Grade L-Alanine Market Challenges
10.4 Pharmaceutical Grade L-Alanine Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Pharmaceutical Grade L-Alanine was estimated to be worth US$ 7.02 million in 2025 and is projected to reach US$ 9.08 million, growing at a CAGR of 3.8% from 2026 to 2032.
Published Date: 2026-07-09
Pages: 124
USD 3950.00
(Single User License)
The global Pharmaceutical Grade L-Alanine market was valued at US$ 7.02 million in 2025 and is anticipated to reach US$ 9.08 million by 2032, at a CAGR of 3.8% from 2026 to 2032.
Published Date: 2026-04-25
Pages: 120
USD 2900.00
(Single User License)
The global Pharmaceutical Grade L-Alanine market is projected to grow from US$ 6.8 million in 2024 to US$ 8.8 million by 2031, at a CAGR of 3.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-25
Pages: 126
USD 4900.00
(Single User License)
The global market for Pharmaceutical Grade L-Alanine was valued at US$ 6.8 million in the year 2024 and is projected to reach a revised size of US$ 8.8 million by 2031, growing at a CAGR of 3.8% during the forecast period.
Published Date: 2025-02-21
Pages: 76
USD 2900.00
(Single User License)
The global market for Pharmaceutical Grade L-Alanine was estimated to be worth US$ 6.8 million in 2024 and is forecast to a readjusted size of US$ 8.8 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 89
USD 3950.00
(Single User License)
L-Alanine is a nonessential α-amino acid and which is a white crystalline solid or powder without odour. It can be dissolved in water, ethanol, insoluble in ether and acetone. In this report, we are study the Pharmaceutical Grade L-Alanine. Ajinomoto, Evonik and Kyowa Hakko is the major manufacturer of Pharmaceutical Grade L-Alanine in the world.
Published Date: 2024-04-07
Pages: 71
USD 4900.00
(Single User License)
L-Alanine is a nonessential α-amino acid and which is a white crystalline solid or powder without odour. It can be dissolved in water, ethanol, insoluble in ether and acetone. In this report, we are study the Pharmaceutical Grade L-Alanine. Ajinomoto, Evonik and Kyowa Hakko is the major manufacturer of Pharmaceutical Grade L-Alanine in the world.
Published Date: 2024-01-10
Pages: 82
USD 2900.00
(Single User License)
The global market for Pharmaceutical Grade L-Alanine was estimated to be worth US$ 7.02 million in 2025 and is projected to reach US$ 9.08 million, growing at a CAGR of 3.8% from 2026 to 2032.
Published: 2026-07-09
Pages: 124
The global Pharmaceutical Grade L-Alanine market was valued at US$ 7.02 million in 2025 and is anticipated to reach US$ 9.08 million by 2032, at a CAGR of 3.8% from 2026 to 2032.
Published: 2026-04-25
Pages: 120
The global Pharmaceutical Grade L-Alanine market is projected to grow from US$ 6.8 million in 2024 to US$ 8.8 million by 2031, at a CAGR of 3.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-25
Pages: 126
The global market for Pharmaceutical Grade L-Alanine was valued at US$ 6.8 million in the year 2024 and is projected to reach a revised size of US$ 8.8 million by 2031, growing at a CAGR of 3.8% during the forecast period.
Published: 2025-02-21
Pages: 76
The global market for Pharmaceutical Grade L-Alanine was estimated to be worth US$ 6.8 million in 2024 and is forecast to a readjusted size of US$ 8.8 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 89
L-Alanine is a nonessential α-amino acid and which is a white crystalline solid or powder without odour. It can be dissolved in water, ethanol, insoluble in ether and acetone. In this report, we are study the Pharmaceutical Grade L-Alanine. Ajinomoto, Evonik and Kyowa Hakko is the major manufacturer of Pharmaceutical Grade L-Alanine in the world.
Published: 2024-04-07
Pages: 71
L-Alanine is a nonessential α-amino acid and which is a white crystalline solid or powder without odour. It can be dissolved in water, ethanol, insoluble in ether and acetone. In this report, we are study the Pharmaceutical Grade L-Alanine. Ajinomoto, Evonik and Kyowa Hakko is the major manufacturer of Pharmaceutical Grade L-Alanine in the world.
Published: 2024-01-10
Pages: 82
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now